As Brexit Row Becomes Increasingly Anarchic, Is UK's Reputation with Pharma Suffering?, Pharmaphorum
Thursday, March 28, 2019
Jeffry Mann and Paul Ranson provide their perspectives on how discussions around Brexit are affecting life sciences companies and the potential future implications.